Company intelligence / Profile preview

Cancer Network

Cranbury, New Jersey, United States

Ownership: Private
Development stage: Other

Overview

CancerNetwork is a premier digital platform and clinical resource for oncology professionals, serving as the online home for the peer-reviewed journal ONCOLOGY. The platform provides clinicians with the latest research, clinical news, expert perspectives, and educational content across various hematologic and solid tumor malignancies. It aims to assist oncologists and hematologists in staying current with therapeutic advancements, clinical trial data, and best practices in patient care. CancerNetwork is a brand under the MJH Life Sciences portfolio, which acquired the asset in 2019 to expand its reach in the oncology community.

Therapeutic areas: OncologyHematology
Industry: Biomedical IT and Biomedical Data Platforms

Beyond the preview

Go deeper on Cancer Network.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cancer Network.

Explore the full profile